Tagged nucleotides useful for nanopore detection

US10669580B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10669580-B2
Application numberUS-201715684726-A
CountryUS
Kind codeB2
Filing dateAug 23, 2017
Priority dateAug 26, 2016
Publication dateJun 2, 2020
Grant dateJun 2, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to compounds comprising a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore. The present disclosure provides methods of preparing the compounds and for their use as nanopore-detectable tags, in particular, for nanopore-based nucleic acid detection and sequencing.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of structural formula (I) N-P-L-T   (I) wherein, N is a nucleoside; P is an oligophosphate covalently attached to a 5′-O group of the nucleoside, wherein the oligophosphate consists of 3 to 12 phosphate groups; L is a linker covalently attached to a terminal phosphate group of the oligophosphate; and T is a tag covalently attached to the linker, wherein the tag comprises a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore, wherein the negatively-charged polymer moiety comprises a covalently linked chain of from 20 to 50 monomer units selected from the monomer unit structures of formula (1a), (1b), (1c), (1d), (1e), (1f), (1g), (1h), (1i), (1i), (1k), (1l), (1m), and any combinations thereof 2. The compound of claim 1 , wherein the compound has a structural formula (II) wherein, Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine; R is selected from H and OH; n is from 1 to 4; Linker is a linker comprising a covalently bonded chain of 2 to 100 atoms; and Tag is the tag comprising the negatively-charged polymer moiety. 3. The compound of claim 2 , wherein the linker comprises a chemical group selected from the group consisting of: ester, ether, thioether, amine, amide, imide, carbonate, carbamate, squarate, thiazole, thiazolidine, hydrazone, oxime, triazole, dihydropyridazine, phosphodiester, polyethylene glycol (PEG), and any combination thereof. 4. The compound of claim 1 , wherein the compound has a structural formula (III) wherein, Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine; R is selected from H and OH; n is from 1 to 4; L B -X-L A is the linker, wherein (a) L A and L B each independently comprises a chemical moiety selected from the group consisting of: linear (C 1 -C 12 ) alkyl, linear (C 1 -C 12 ) alkene, linear (C 1 -C 12 ) alkyne, ester, ether, thioether, amine, amide, imide, carbonate, carbamate, squarate, thiazole, thiazolidine, hydrazone, oxime, triazole, dihydropyridazine, phosphodiester, polyethylene glycol (PEG), and combinations thereof; and (b) X comprises a chemical moiety selected from the group consisting of ester, ether, thioether, amine, amide, imide, carbonate, carbamate, squarate, thiazole, thiazolidine, hydrazone, oxime, triazole, and dihydropyridazine; and Tag is the tag comprising the negatively-charged polymer moiety. 5. The compound of claim 4 , wherein the compound has a structural formula (IIIa) wherein, Base is selected from adenosine, cytidine, guanosine, thymidine, and uridine; R is selected from H and OH; n is from 1 to 4; p is from 2 to 10; and Tag is the tag comprising the negatively-charged polymer moiety. 6. The compound of claim 5 , wherein R=H, n=4, and p=5. 7. The compound of claim 1 , wherein the increased ion flow results in a measured current across the nanopore that is greater than O.C. current, optionally at least 5% greater than O.C. current, at least 10% greater than O.C. current, at least 25% greater than O.C. current, or at least 50% greater than O.C. current. 8. The compound of claim 1 , wherein the negatively-charged polymer moiety has an overall negative charge of from (−25) to (−50), optionally an overall negative charge of from (−30) to (−40), or optionally an overall negative charge of from (−31) to (−37). 9. The compound of claim 1 , wherein the negatively-charged polymer moiety comprises a covalently linked chain of from 25 to 40 monomer units. 10. The compound of claim 1 , wherein the negatively-charged polymer moiety comprises a formula (A)m-(B)n-(C)p-(D)q, wherein A, B, C, and D, are monomer units independently selected from the monomer unit structures of formula (1a), (1b), (1c), (1d), (1e), (1f), (1g), (1h), (1i), (1j), (1k), (1l), and (1m), and each of m, n, p, and q is from 0 to 40, and m+n+p+q is from 20 to 40. 11. The compound of claim 1 , wherein the negatively-charged polymer moiety is selected from the group consisting of: -TF-(SpC2) 28 - (SEQ ID NO: 1), -TT-(SpC3) 28 - (SEQ ID NO: 2), -(SpC3) 31 - (SEQ ID NO: 3), -TT-(dSp) 26 -TT- (SEQ ID NO: 4), -TF-(SpC4-F4) 28 - (SEQ ID NO: 5), -TT-(SpC7-Pra2) 28 - (SEQ ID NO: 6), -(SpC2) 8 -T 6 -(SpC2) 16 - (SEQ ID NO: 12), -(SpC2) 8 -(N3CEdT) 7 -(SpC2) 15 - (SEQ ID NO: 13), -(SpC2) 6 -TT-(BHEB)-T-(SpC2) 20 -(SEQ ID NO: 14, -(SpC2) 9 -T-(BHEB) 2 -T-(SpC2) 17 - (SEQ ID NO: 15), and -(SpC2) 8 -(S500) 3 -(SpC2) 17 - (SEQ ID NO: 16). 12. A composition comprising a set of compounds, each compound of the set comprising a different tag which results in a different flow of positive ions through a nanopore when the tag enters the nanopore, wherein at least one of the compounds of the set is a compound according to claim 1 .

Assignees

Inventors

Classifications

  • Release of bound markers · CPC title

  • being a sensor, e.g. electrode · CPC title

  • incorporating a spacer/coupling moiety · CPC title

  • Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

  • DNA polymerase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10669580B2 cover?
The present disclosure relates to compounds comprising a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore. The present disclosure provides methods of preparing the compounds and for their use as nanopore-detectable tags, in particular, for…
Who is the assignee on this patent?
Roche Sequencing Solutions Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).